Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations | Zendy

Matteo Lambertini | Zendy; Lieveke Ameye | Zendy; Anne-Sophie Hamy | Zendy; Anna Zingarello | Zendy; Philip D. Poorvu | Zendy; Estela Carrasco | Zendy; Albert Grinshpun | Zendy; Sileny Han | Zendy; Christine RoussetJablonski | Zendy; Alberta Ferrari | Zendy; Shani PaluchShimon | Zendy; Laura Cortesi | Zendy; Claire Sénéchal | Zendy; Gianmaria Miolo | Zendy; Katarzyna Pogoda | Zendy; José Alejandro Pérez Fidalgo | Zendy; Laura De Marchis | Zendy; Riccardo Ponzone | Zendy; Luca Livraghi | Zendy; Maria Del Pilar Estevez Diz | Zendy; Cynthia VillarrealGarza | Zendy; Maria Vittoria Dieci | Zendy; Florian Clatot | Zendy; Martine Berlière | Zendy; Rossella Graffeo | Zendy; Luís Teixeira | Zendy; Octavi Córdoba | Zendy; Amir Sonnenblick | Zendy; Helena Luna Pais | Zendy; Michail Ignatiadis | Zendy; Marianne Paesmans | Zendy; Ann H. Partridge | Zendy; Olivier Caron | Zendy; Claire Saule | Zendy; Lucia Del Mastro | Zendy; Fedro A. Peccatori | Zendy; Hatem A. Azim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations

Author(s) -

Matteo Lambertini,

Lieveke Ameye,

Anne-Sophie Hamy,

Anna Zingarello,

Philip D. Poorvu,

Estela Carrasco,

Albert Grinshpun,

Sileny Han,

Christine RoussetJablonski,

Alberta Ferrari,

Shani PaluchShimon,

Laura Cortesi,

Claire Sénéchal,

Gianmaria Miolo,

Katarzyna Pogoda,

José Alejandro Pérez Fidalgo,

Laura De Marchis,

Riccardo Ponzone,

Luca Livraghi,

Maria Del Pilar Estevez Diz,

Cynthia VillarrealGarza,

Maria Vittoria Dieci,

Florian Clatot,

Martine Berlière,

Rossella Graffeo,

Luís Teixeira,

Octavi Córdoba,

Amir Sonnenblick,

Helena Luna Pais,

Michail Ignatiadis,

Marianne Paesmans,

Ann H. Partridge,

Olivier Caron,

Claire Saule,

Lucia Del Mastro,

Fedro A. Peccatori,

Hatem A. Azim

Publication year - 2020

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.19.02399

Subject(s) - medicine , breast cancer , pregnancy , hazard ratio , brca mutation , cancer , gynecology , oncology , obstetrics , germline , retrospective cohort study , germline mutation , mutation , confidence interval , genetics , gene , biology

PURPOSE Young women with germline BRCA mutations have unique reproductive challenges. Pregnancy after breast cancer does not increase the risk of recurrence; however, very limited data are available in patients with BRCA mutations. This study investigated the impact of pregnancy on breast cancer outcomes in patients with germline BRCA mutations.PATIENTS AND METHODS This is an international, multicenter, hospital-based, retrospective cohort study. Eligible patients were diagnosed between January 2000 and December 2012 with invasive early breast cancer at age ≤ 40 years and harbored deleterious germline BRCA mutations. Primary end points were pregnancy rate, and disease-free survival (DFS) between patients with and without a pregnancy after breast cancer. Pregnancy outcomes and overall survival (OS) were secondary end points. Survival analyses were adjusted for guarantee-time bias controlling for known prognostic factors.RESULTS Of 1,252 patients with germline BRCA mutations ( BRCA1, 811 patients; BRCA2, 430 patients; BRCA1/2, 11 patients) included, 195 had at least 1 pregnancy after breast cancer (pregnancy rate at 10 years, 19%; 95% CI, 17% to 22%). Induced abortions and miscarriages occurred in 16 (8.2%) and 20 (10.3%) patients, respectively. Among the 150 patients who gave birth (76.9%; 170 babies), pregnancy complications and congenital anomalies occurred in 13 (11.6%) and 2 (1.8%) cases, respectively. Median follow-up from breast cancer diagnosis was 8.3 years. No differences in DFS (adjusted hazard ratio [HR], 0.87; 95% CI, 0.61 to 1.23; P = .41) or OS (adjusted HR, 0.88; 95% CI, 0.50 to 1.56; P = .66) were observed between the pregnancy and nonpregnancy cohorts.CONCLUSION Pregnancy after breast cancer in patients with germline BRCA mutations is safe without apparent worsening of maternal prognosis and is associated with favorable fetal outcomes. These results provide reassurance to patients with BRCA-mutated breast cancer interested in future fertility.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research